I have performed patient-derived xenograft model (PDX) using NOG mice.

3 out of 10 mice in which tumor has grown has been shown to be malignant B cell lymphoma positive for CD20.

Several papers indicated that Epsteiin-Barr virus infection is responsible for lymphoma development in this immunodeficinet mice.

Therefore, I would like to know how to prevent the lymphoma development in the xenograft models in NOG mice?

Thank you in advance.

Go

More Go J Yoshida's questions See All
Similar questions and discussions